DK1326654T3 - Fremgangsmåder og sammensætninger til vævsregeneration - Google Patents

Fremgangsmåder og sammensætninger til vævsregeneration

Info

Publication number
DK1326654T3
DK1326654T3 DK01966441T DK01966441T DK1326654T3 DK 1326654 T3 DK1326654 T3 DK 1326654T3 DK 01966441 T DK01966441 T DK 01966441T DK 01966441 T DK01966441 T DK 01966441T DK 1326654 T3 DK1326654 T3 DK 1326654T3
Authority
DK
Denmark
Prior art keywords
compositions
methods
organ
tissue regeneration
unencapsulated
Prior art date
Application number
DK01966441T
Other languages
English (en)
Inventor
Edward E Baetge
Thomas Hunziker
Vincent Ronfard
Original Assignee
Dfb Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dfb Pharmaceuticals Inc filed Critical Dfb Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1326654T3 publication Critical patent/DK1326654T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Materials Engineering (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01966441T 2000-09-01 2001-08-31 Fremgangsmåder og sammensætninger til vævsregeneration DK1326654T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23028600P 2000-09-01 2000-09-01
US29900301P 2001-06-18 2001-06-18
US09/943,114 US6673603B2 (en) 2000-09-01 2001-08-30 Cell paste comprising keratinocytes and fibroblasts
PCT/US2001/027104 WO2002017980A2 (en) 2000-09-01 2001-08-31 Methods and compositions for tissue regeneration

Publications (1)

Publication Number Publication Date
DK1326654T3 true DK1326654T3 (da) 2007-02-19

Family

ID=27398066

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01966441T DK1326654T3 (da) 2000-09-01 2001-08-31 Fremgangsmåder og sammensætninger til vævsregeneration

Country Status (10)

Country Link
US (1) US6673603B2 (da)
EP (1) EP1326654B1 (da)
AT (1) ATE342741T1 (da)
AU (1) AU8695201A (da)
CA (1) CA2426107C (da)
DE (1) DE60123988T2 (da)
DK (1) DK1326654T3 (da)
ES (1) ES2274903T3 (da)
PT (1) PT1326654E (da)
WO (1) WO2002017980A2 (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004536018A (ja) 2000-07-31 2004-12-02 バル・イラン・ユニバーシティ 創傷治療のための方法および薬学的組成物
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
US7144729B2 (en) * 2000-09-01 2006-12-05 Dfb Pharmaceuticals, Inc. Methods and compositions for tissue regeneration
AUPR298901A0 (en) 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
US7297343B2 (en) * 2001-07-31 2007-11-20 Biosurface Engineering Technologies, Inc. Bioactive medical films
WO2003041568A2 (en) * 2001-11-15 2003-05-22 University Of Medicine & Dentistry Of New Jersey A three-dimensional matrix for producing living tissue equivalents
WO2003072128A2 (en) * 2002-02-22 2003-09-04 Ebi, L.P. Methods and compositions for treating bone or cartilage defects
US7744597B2 (en) * 2002-06-26 2010-06-29 Lifenet Health Device and process for producing fiber products and fiber products produced thereby
US7498040B2 (en) 2005-10-12 2009-03-03 Lifenet Health Compositions for repair of defects in osseous tissues, and methods of making the same
US20050271738A1 (en) * 2002-07-26 2005-12-08 Ebi, L.P. Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus
AU2012241057B2 (en) * 2002-09-06 2015-06-11 Smith & Nephew Orthopaedics Ag Methods and Compositions for Tissue Regeneration
US7494811B2 (en) 2003-05-01 2009-02-24 Lifenet Health In vitro growth of tissues suitable to the formation of bone and bone forming tissue formed thereby
RU2358753C2 (ru) 2003-08-07 2009-06-20 Хилор Лтд. Фармацевтические композиции и способы для ускорения заживления ран
US7744869B2 (en) * 2003-08-20 2010-06-29 Ebi, Llc Methods of treatment using electromagnetic field stimulated mesenchymal stem cells
US20050054100A1 (en) * 2003-09-08 2005-03-10 Rennard Stephen I. Methods for fibroblast differentiation
WO2007024972A2 (en) * 2005-08-22 2007-03-01 Quick-Med Technologies, Inc. Non-leaching absorbent wound dressing
ZA200802546B (en) 2005-08-29 2009-10-28 Healor Ltd Methods and compositions for prvention and treatment of diabetic and aged skin
TW200731982A (en) * 2005-10-17 2007-09-01 Aderans Res Inst Inc Method of delivering cells to the skin
US20070105769A1 (en) * 2005-11-07 2007-05-10 Ebi, L.P. Methods of treating tissue defects
TW200803877A (en) * 2005-11-22 2008-01-16 Aderans Res Inst Inc Hair grafts derived from plucked hair
US20070154448A1 (en) 2005-11-22 2007-07-05 Ted Reid Methods and compositions using Substance P to promote wound healing
TW200800240A (en) * 2005-11-22 2008-01-01 Aderans Res Inst Inc Hair follicle graft from tissue engineered skin
US8273702B2 (en) * 2006-02-17 2012-09-25 Wake Forest University Health Sciences Wound healing compositions containing keratin biomaterials
EP2101724B1 (en) 2006-05-11 2020-12-02 Regenics AS Administration of cellular extracts for rejuvenation
RU2009117828A (ru) * 2006-10-13 2010-11-20 Релайанс Лайф Сайенсиз Пвт. Лтд. (In) Культивированные меланоциты на биополимерах
US8034014B2 (en) 2007-03-06 2011-10-11 Biomet Biologics, Llc Angiogenesis initation and growth
US7985537B2 (en) * 2007-06-12 2011-07-26 Aderans Research Institute, Inc. Methods for determining the hair follicle inductive properties of a composition
DK2296676T3 (da) 2008-05-09 2016-12-19 Regenics As Cellulære ekstrakter
GB0820492D0 (en) * 2008-11-07 2008-12-17 Sportcell Cell compositions and uses thereof
RU2012134041A (ru) 2010-01-11 2014-02-20 Хилор Лтд. Способ лечения воспалительного заболевания и расстройства
WO2011138687A2 (en) 2010-05-06 2011-11-10 Regenics As Use of cellular extracts for skin rejuvenation
GB201014097D0 (en) * 2010-08-24 2010-10-06 King S College London Treatment
WO2012048275A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
EP2828378B1 (en) * 2012-03-22 2021-02-17 Avita Medical Ltd Cell suspension and use thereof
AU2013356930B2 (en) 2012-12-10 2017-01-05 Regenics As Use of egg cellular extracts for skin rejuvenation
FR2999083B1 (fr) 2012-12-12 2015-01-23 Univ Nantes Pansement contenant des fibroblastes et des keratinocytes foetaux
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
CN106163542A (zh) * 2014-02-05 2016-11-23 雷波内制药有限公司 用于促进皮肤溃疡和伤口愈合的组合物
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2015171074A1 (en) * 2014-05-05 2015-11-12 National University Of Singapore Methods of producing tissue-mimetic constructs and uses thereof
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2016154206A1 (en) 2015-03-26 2016-09-29 Smith & Nephew, Inc. Biopreservation medium and uses for biopreservation of biological materials
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
EP3132809A1 (en) 2015-08-21 2017-02-22 Bioskinco GmbH Composition and products comprising senescent cells for use in tissue regeneration
WO2017187287A1 (en) 2016-04-25 2017-11-02 Smith & Nephew, Inc. Medium for biopreservation of cells and other biological materials at cryogenic and hypothermic conditions and uses thereof
EP3464565A4 (en) 2016-05-25 2020-01-01 Terumo BCT, Inc. CELL EXPANSION
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3656842A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion
JP2024511064A (ja) 2021-03-23 2024-03-12 テルモ ビーシーティー、インコーポレーテッド 細胞捕獲及び増殖
CN113679889B (zh) * 2021-07-20 2022-10-25 杭州贤石生物科技有限公司 一种脱细胞基质复合材料及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460939A (en) * 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
US4904259A (en) 1988-04-29 1990-02-27 Samuel Itay Compositions and methods for repair of cartilage and bone
US5290552A (en) 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
GB8901676D0 (en) 1989-01-26 1989-03-15 Ici Plc Regulation of gene expression
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
DE69333924T2 (de) 1992-05-29 2006-08-17 University Of North Carolina At Chapel Hill Im immobilisierten Zustand getrocknete pharmazeutisch verträgliche menschliche Blutplättchen
GB9516556D0 (en) 1995-08-12 1995-10-11 Smith & Nephew Cell culture laminate
US6419920B1 (en) * 1995-10-25 2002-07-16 Trans Karyotic Therapies, Inc. Hybrid matrix implants and explants
JP2000508922A (ja) * 1996-04-26 2000-07-18 ケース ウエスターン リザーブ ユニバーシティ 間葉幹細胞を用いる皮膚再生
US5968546A (en) 1997-05-16 1999-10-19 Baur; Marcus Keratinocyte culture from precursor cells
JP2002527144A (ja) * 1998-10-12 2002-08-27 セリックス， インコーポレイテッド 組織再生のための複合体およびその製造方法
AU777833B2 (en) 1999-10-05 2004-11-04 Transkaryotic Therapies, Inc. Hybrid matrices and hybrid matrix mixtures
US20030091543A1 (en) * 2001-10-26 2003-05-15 Klein Matthew B. Therapeutic cell preparation grafts and methods of use thereof

Also Published As

Publication number Publication date
WO2002017980A9 (en) 2003-03-20
US20020048563A1 (en) 2002-04-25
ES2274903T3 (es) 2007-06-01
WO2002017980B1 (en) 2002-08-15
EP1326654B1 (en) 2006-10-18
DE60123988T2 (de) 2007-06-14
US6673603B2 (en) 2004-01-06
EP1326654A2 (en) 2003-07-16
ATE342741T1 (de) 2006-11-15
WO2002017980A2 (en) 2002-03-07
AU8695201A (en) 2002-03-13
CA2426107A1 (en) 2002-03-07
PT1326654E (pt) 2007-02-28
DE60123988D1 (de) 2006-11-30
WO2002017980A3 (en) 2002-05-30
CA2426107C (en) 2011-01-18

Similar Documents

Publication Publication Date Title
DK1326654T3 (da) Fremgangsmåder og sammensætninger til vævsregeneration
EP1545565A4 (en) METHODS AND COMPOSITIONS FOR TISSUE REGENERATION
Boyce et al. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes
EP1312383A3 (en) Resorbable extracellular matrix containing collagen I and collagen II for reconstruction of cartilage
MX2007010674A (es) Composiciones y metodos para la aplicacion topica y el suministro transdermico de un oligopeptido.
Prato et al. Tissue engineering technology for gingival augmentation procedures: a case report.
KR101912329B1 (ko) 세포 외 기질을 모사한 피부 세포 재생용 화장료 조성물
IL160188A0 (en) Materials and methods to promote repair of nerve tissue
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
GB2434105A (en) Fibronectin-modified ECM tissue graft constructs and methods for preparation and use thereof
DaCosta et al. Diphenylhydantoin sodium promotes early and marked angiogenes is and results in increased collagen deposition and tensile strength in healing wounds
Armstrong et al. Punch biopsy wounds treated with Monsel's solution or a collagen matrix: a comparison of healing
BRPI0510257A (pt) uso de peptìdeos kikvav na preparação de composições cosméticas para melhoria da firmeza da pele através do aumento da adesão celular
Álvaro-Afonso et al. Advances in dermoepidermal skin substitutes for diabetic foot ulcers
WO2002007749A3 (en) Device providing regulated growth factor delivery for the regeneration of peripheral nerves
CN110522671A (zh) 一种深度补水复合物及其制备方法
Luczyszyn et al. Histologic analysis of the acellular dermal matrix graft incorporation process: a pilot study in dogs.
BR0312365A (pt) Meio de cultura autólogo de células-mães progenitoras autólogas humanas, métodos para a preparação do mesmo e de uma composição de células-mães progenitoras autólogas humanas e para a obtenção de células-mães progenitoras musculares autólogas humanas, emprego de um meio de cultura autólogo de células-mães progenitoras autólogas humanas, procedimento para a obtenção de células-mães progenitoras musculares autólogas humanas e procedimento terapêutico de cardiomioplastia celular autóloga, composição enriquecida com células-mães progenitoras musculares autólogas humanas e composição farmacêutica
Kadam et al. Treatment of gingival recession defect using human umbilical cord mesenchymal stem cells cultured on PCL based bone regenerating scaffold: a randomized controlled clinical study
ATE225183T1 (de) Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen
IT201800011056A1 (it) Composizione per la prevenzione ed il trattamento delle affezioni cutanee
WO2012160484A1 (en) Hydrogel composition and uses thereof
JP2023551063A (ja) 皮膚及び粘膜の外傷性病変を治癒するための製剤
Trouillas et al. HGF, MMPs and TGF-β1 contribute to INTERLEUKIN-1β primed mesenchymal stromal cells effect on wound healing and epidermal substitute engraftment
Gaudard et al. Treatment of multiple gingival recessions with tunnel procedure and a new xenogeneic collagen matrix